Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
The Scientist
Most Recent
Dengue virus has sophisticated mechanisms for entering a cell, for replicating its RNA genome, and for transcribing proteins.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A healthcare professional warns that cold and flu seasons peak in mid-February, so it may be wise take a rain check on kissing, cuddling, and pillow sharing today.
In a pond, more amphibian species mean decreased chances of disease spread.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
